1358 — PW Medtech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual cashflow statement for PW Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	85.8	627	737	158	231
Depreciation
Amortisation
Non-Cash Items	-29.8	-633	-736	33.5	-58.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	14.6	55.9	4.73	-0.578	-60.1
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	100	78.2	37.2	269	211
Capital Expenditures	-47.4	-7.88	-11.3	-61.9	-81.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1.63	2,078	2,648	-1,020	55.2
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-45.8	2,070	2,636	-1,082	-26.7
Financing Cash Flow Items	-30.1	-10.7	-0.604	1.54	89.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-20.3	-578	-2,091	-85.2	17.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	33.6	1,569	583	-903	208